Ariana Pharmaceuticals SA
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ariana Pharmaceuticals SA
AbbVie pays $130m up front with up to $870m in earnout potential for UCB spinout focused on SV2A modulators. BioNTech gets rights to preclinical TCR candidates for solid tumors from Medigene.
Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
- Contract Research Organization-CRO
- Artificial Intelligence
- Drug Discovery Tools